SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (2880)3/20/1998 8:36:00 PM
From: Hank  Read Replies (1) of 7041
 
I think SGP is trying to get whatever they can out of Vasomax. I think ZONA presented SGP with misleading data on Vasomax to entice them into becoming a partner. Once SGP got the chance to test the drug for themselves, I think they realized that it was marginably effect at best. Hence, they are going for the third world markets like Mexico where the regulatory rules are lax. I think they realize that Vasomax is no match for Viagra and offers no tangible benefit by comparison. How do you know that they are actively pursuing further development in preparation for an NDA filing in the US? Have you confirmed this with them? I have seen NO statements from SGP lately that would confirm this. Please point me to the press release.

I am a research consultant for the drug discovery unit of a major pharmaceutical company and I have a PhD in Biochemistry.

Hank
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext